Source: International Congress 2015 – Treatment of IPF
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin Scally (Edinburgh, United Kingdom), Benjamin Scally, Andreas Alber, Sarah Howie, Nik Hirani. LSC Abstract – Inhibition of oxygen sensing HIF prolyl hydroxylases in humans presents a novel therapeutic target for the fibrotic lung. Eur Respir J 2015; 46: Suppl. 59, 4496

Member's Comments

No comment yet.

Related content which might interest you: Imaging of the HIF pathway – clues on oxygen sensing Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 HIF pathway activation is a core regulator of collagen structure-function in lung fibrosis Source: Virtual Congress 2020 – Lung epithelial development and repair in three-dimensions Year: 2020 Targeting intermittent hypoxia downstream pathways for biomarker discovery and new treatment perspectives in cutaneous melanoma Source: Eur Respir J, 53 (2) 1802444; 10.1183/13993003.02444-2018 Year: 2019 Localisation of NADPH oxidases and their role in hypoxia induced pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 804s Year: 2006 Role of the JAK/STAT pathway in activation of the xanthine dehydrogenase/oxidase in lung microvascular endothelial cells exposure to hypoxia Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Upregulated HIF (hypoxia inducible factor)-1 DNA binding activity to VEGF-a promoter mediates oedema formation in donor lung grafts Source: Eur Respir J 2003; 22: Suppl. 45, 7s Year: 2003 Targeting AMPK and the Nrf2/HO-1 axis: a promising therapeutic strategy in acute lung injury Source: Eur Respir J, 58 (6) 2102238; 10.1183/13993003.02238-2021 Year: 2021 A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels Source: Eur Respir J, 51 (4) 1702229; 10.1183/13993003.02229-2017 Year: 2018 Targeting metabolic reprogramming as a novel anti-fibrotic strategy Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 SH2 domain-containing Phosphatase-(SHP)-2 blunts fibrotic responses through regulation of fibroblast mitochondrial metabolism and autophagy Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Sirtuins inhibition modulates endotoxin-induced lung inflammation Source: Annual Congress 2010 - Models of airways disease Year: 2010 Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Late Breaking Abstract - Role of HIF2a oxygen sensing pathway in bronchial epithelium biology Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Glutathione redox regulates TGF-β-induced Smad activation and fibrogenic effect in human airway Source: Eur Respir J 2007; 30: Suppl. 51, 496s Year: 2007 Gene regulatory roles for lysyl oxidases in the context of BPD Source: International Congress 2017 – Molecular biology of normal and abnormal lung development Year: 2017 Role of lysyl oxidases in pathogenesis of pulmonary emphysema Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017